57 results on '"Liebold, Andreas"'
Search Results
2. Intraoperative haemoadsorption for antithrombotic drug removal during cardiac surgery: initial report of the international safe and timely antithrombotic removal (STAR) registry.
- Author
-
Schmoeckel, Michael, Thielmann, Matthias, Hassan, Kambiz, Geidel, Stephan, Schmitto, Jan, Meyer, Anna L., Vitanova, Keti, Liebold, Andreas, Marczin, Nandor, Bernardi, Martin H., Tandler, Rene, Lindstedt, Sandra, Matejic-Spasic, Marijana, Wendt, Daniel, Deliargyris, Efthymios N., and Storey, Robert F.
- Abstract
Intraoperative antithrombotic drug removal by haemoadsorption is a novel strategy to reduce perioperative bleeding in patients on antithrombotic drugs undergoing cardiac surgery. The international STAR registry reports real-world clinical outcomes associated with this application. All patients underwent cardiac surgery before completing the recommended washout period. The haemoadsorption device was incorporated into the cardiopulmonary bypass (CPB) circuit. Patients on P2Y
12 inhibitors comprised group 1, and patients on direct-acting oral anticoagulants (DOAC) group 2. Outcome measurements included bleeding events according to standardised definitions and 24-hour chest-tube-drainage (CTD). 165 patients were included from 8 institutions in Austria, Germany, Sweden, and the UK. Group 1 included 114 patients (62.9 ± 11.6years, 81% male) operated at a mean time of 33.2 h from the last P2Y12 inhibitor dose with a mean CPB duration of 117.1 ± 62.0 min. Group 2 included 51 patients (68.4 ± 9.4years, 53% male), operated at a mean time of 44.6 h after the last DOAC dose, with a CPB duration of 128.6 ± 48.4 min. In Group 1, 15 patients experienced a BARC-4 bleeding event (13%), including 3 reoperations (2.6%). The mean 24-hour CTD was 651 ± 407mL. In Group 2, 8 patients experienced a BARC-4 bleeding event (16%) including 4 reoperations (7.8%). The mean CTD was 675 ± 363mL. This initial report of the ongoing STAR registry shows that the intraoperative use of a haemoadsorption device is simple and safe, and may potentially mitigate the expected high bleeding risk of patients on antithrombotic drugs undergoing cardiac surgery before completion of the recommended washout period. Clinical registration number: ClinicalTrials.gov identifier: NCT05077124. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
3. Feasibility of aligning creatine kinase MB activity and mass data in multicentre trials using generalized additive modelling.
- Author
-
Hoenicka, Markus, Vokshi, Arbresha, Zhou, Shaoxia, Liebold, Andreas, and Mayer, Benjamin
- Published
- 2024
- Full Text
- View/download PDF
4. Epicardial and endocardial surgical ablation of atrial fibrillation: outcomes from CASE-AF Registry.
- Author
-
Mitrovic, Ivana, Eszlari, Edgar, Cvorak, Adi, Liebold, Andreas, Rastan, Ardawan, Grubitzsch, Herko, Knaut, Michael, Fischlein, Theodor, Ouarrak, Taoufik, Senges, Jochen, Hanke, Thorsten, Doll, Nicolas, and Eichinger, Walter
- Published
- 2024
- Full Text
- View/download PDF
5. Target flow deviations on the cardiopulmonary bypass cause postoperative delirium in cardiothoracic surgery—a retrospective study evaluating temporal fluctuations of perfusion data.
- Author
-
Krefting, Johannes, Gorki, Hagen, Hoenicka, Markus, Albrecht, Günter, Kraft, Robert, and Liebold, Andreas
- Published
- 2024
- Full Text
- View/download PDF
6. 2021 MiECTiS focused update on the 2016 position paper for the use of minimal invasive extracorporeal circulation in cardiac surgery.
- Author
-
Anastasiadis, Kyriakos, Antonitsis, Polychronis, Murkin, John, Serrick, Cyril, Gunaydin, Serdar, El-Essawi, Aschraf, Bennett, Mark, Erdoes, Gabor, Liebold, Andreas, Punjabi, Prakash, Theodoropoulos, Konstantinos C, Kiaii, Bob, Wahba, Alexander, de Somer, Filip, Bauer, Adrian, Kadner, Alexander, van Boven, Wim, Argiriadou, Helena, Deliopoulos, Apostolos, and Baker, Robert Α
- Subjects
ARTIFICIAL blood circulation ,CARDIAC surgery ,CONSENSUS (Social sciences) ,OCTOGENARIANS ,ANESTHESIA ,MINIMALLY invasive procedures ,HEART ,BLOOD transfusion ,ATRIAL fibrillation ,MEDICAL care ,CARDIOVASCULAR system ,REOPERATION ,COST effectiveness ,QUALITY of life ,INTERNATIONAL agencies ,TECHNOLOGY ,PATIENT care ,CARDIOPULMONARY bypass ,PERFUSION - Abstract
The landmark 2016 Minimal Invasive Extracorporeal Technologies International Society (MiECTiS) position paper promoted the creation of a common language between cardiac surgeons, anesthesiologists and perfusionists which led to the development of a stable framework that paved the way for the advancement of minimal invasive perfusion and related technologies. The current expert consensus document offers an update in areas for which new evidence has emerged. In the light of published literature, modular minimal invasive extracorporeal circulation (MiECC) has been established as a safe and effective perfusion technique that increases biocompatibility and ultimately ensures perfusion safety in all adult cardiac surgical procedures, including re-operations, aortic arch and emergency surgery. Moreover, it was recognized that incorporation of MiECC strategies advances minimal invasive cardiac surgery (MICS) by combining reduced surgical trauma with minimal physiologic derangements. Minimal Invasive Extracorporeal Technologies International Society considers MiECC as a physiologically-based multidisciplinary strategy for performing cardiac surgery that is associated with significant evidence-based clinical benefit that has accrued over the years. Widespread adoption of this technology is thus strongly advocated to obtain additional healthcare benefit while advancing patient care. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Improving adult pulsatile minimal invasive extracorporeal circulation in a mock circulation.
- Author
-
Dürr, Anke, Weber, Elena, Eisenmann, Lisa, Albrecht, Günter, Liebold, Andreas, and Hoenicka, Markus
- Subjects
ARTIFICIAL blood circulation ,OXYGENATORS ,PULSATILE flow ,CATHETERS ,CARDIAC surgery ,HEMODYNAMICS - Abstract
Background: Pulsatile extracorporeal circulation (ECC) may improve perfusion of critical organs during cardiac surgery. This study analyzed the influence of the components of a minimal invasive ECC (MiECC) on the transfer of pulsatile energy into the pseudo‐patient of a mock circulation. Methods: An aortic model with human‐like geometry and compliance was perfused by a diagonal pump. Surplus hemodynamic energy (SHE) was determined from flow and pressure data. Five adult‐size oxygenator models and three sizes of cannulas were compared. Pulsatile pump settings were optimized, and parallel dual‐pump configurations were evaluated. Results: Oxygenator models showed up to twofold differences in pressure gradients and influenced SHE at flow rates up to 2.0 L min−1. Adjustments of frequency, systole duration, and rotational speed gain significantly improved SHE compared with empirical settings, with SHE above 21% of mean arterial pressure at flow rates of 1.0 L min−1 to 1.5 L min−1 and SHE above 5% at 3.5 L min−1. Small diameter cannula (15 Fr) limited SHE compared with larger cannula (21 Fr and 23 Fr). Two diagonal pumps did not provide higher SHE than a single pump, but permitted additional control over pulse pressure and SHE by varying the total fraction of pulsatile flow and the fraction of flow bypassing the oxygenator. Conclusions: Proper selection of components and optimizations of pump settings significantly improved pulse pressure and SHE of pulsatile MiECC. Surplus hemodynamic energy depended on flow rate with a maximum at 1.0 L min−1–1.5 L min−1. Pulsatile MiECC may specifically assist organ perfusion during phases of low flow. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. A novel pulsatile blood pump design for cardiothoracic surgery: Proof‐of‐concept in a mock circulation.
- Author
-
Weber, Elena, Chong, Albert, Liebold, Andreas, and Hoenicka, Markus
- Subjects
PULSATILE flow ,ARTIFICIAL blood circulation ,HEART beat ,PATIENT compliance ,HEMODYNAMICS ,OXYGENATORS - Abstract
Background: Pulsatile perfusion during extracorporeal circulation is a promising concept to improve perfusion of critical organs. Clinical benefits are limited by the amount of pulsatile energy provided by standard pumps. The present study investigated the properties of a novel positive displacement blood pump in a mock circulation. Methods: The pump was attached to an aortic model with a human‐like geometry and compliance as a pseudo patient. Hemodynamic data were recorded while the pump settings were adjusted systematically. Results: Using a regular oxygenator, maximum flow was 2.6 L/min at a pressure of 27 mm Hg and a frequency (F) of 90 bpm. Pulse pressure (PP; 28.9 mm Hg) and surplus hemodynamic energy (SHE; 26.1% of mean arterial pressure) were highest at F = 40 bpm. Flow and pressure profiles appeared sinusoid. Using a low‐resistance membrane ventilator to assess the impact of back pressure, maximum flow was 4.0 L/min at a pressure of 58.6 mm Hg and F = 40 bpm. At F = 40 bpm, PP was 58.7 mm Hg with an SHE of 33.4%. SHE decreased with increasing flow, heart rate, and systolic percentage but surpassed 10% with reasonable settings. Conclusions: The present prototype achieved sufficient flow and pressure ranges only in the presence of a low‐resistance membrane ventilator. It delivered supraphysiologic levels of pulse pressure and SHE. Further modifications are planned to establish this concept for adult pulsatile perfusion. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Anterior Pathway for Epicardial Left Atrial Appendage Clip Occlusion During Minimally Invasive Atrioventricular Valve Surgery.
- Author
-
Vondran, Maximilian, Rose, Frank, Treede, Hendrik, Liebold, Andreas, Doll, Nicolas, Choi, Yeong-Hoon, and Kaminski, Alexander
- Published
- 2022
- Full Text
- View/download PDF
10. Preservation of Adrenoceptor and Endothelin Receptor Mediated Vasoconstriction and of Endothelium-Dependent Relaxation after Cold Storage of Explanted Blood Vessels for ex vivo Analyses.
- Author
-
Hoenicka, Markus, Sabau, Marius, Liebold, Andreas, Hofmann, Hans-Stefan, and Ried, Michael
- Subjects
ENDOTHELIN receptors ,COLD storage ,BLOOD vessels ,VASOCONSTRICTION ,SAPHENOUS vein - Abstract
Introduction: Adrenoceptor and endothelin (ET) receptor-mediated vasoconstriction as well as endothelium-dependent vasodilation of human saphenous veins were compared before and after 20 h of cold storage. Methods: Contractile responses to potassium chloride (KCl), norepinephrine (NE), and ET-1 as well as vasodilator responses to acetylcholine (ACh) were evaluated. Results: Storage in HEPES-supplemented Dulbecco's modified Eagle's medium (HDMEM) diminished KCl induced contractile forces to 71% (p = 0.002) and NE induced contractions to 80% (p = 0.037), in contrast to HEPES-supplemented Krebs-Henseleit solution (HKH) and TiProtec solution. KCl-normalized NE contractions were not affected by storage. NE EC
50 values were slightly lower (7.1E−8 vs. 7.5E−8, p = 0.019) after storage in HKH, with no changes after storage in the other solutions. Endothelium-dependent responses to ACh were not affected by storage. ET-1 induced contractions were attenuated after storage in HDMEM (77%, p = 0.002), HKH (75%, p = 0.020), and TiProtec (73%, p = 0.010) with no changes in normalized constrictions. ET-1 EC50 values were not affected by storage. Conclusion: Loss of contractility after storage in HDMEM may reflect the lower content of dextrose. There was no specific attenuation of adrenoceptor, ET-receptor, or ACh receptor mediated signal transduction after storage in any of the media. HKH or TiProtec are equally suitable cold storage solutions for ex vivo measurements. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
11. value of perioperative biomarker release for the assessment of myocardial injury or infarction in cardiac surgery.
- Author
-
Schneider, Ulrich, Mukharyamov, Murat, Beyersdorf, Friedhelm, Dewald, Oliver, Liebold, Andreas, Gaudino, Mario, Fremes, Stephen, and Doenst, Torsten
- Subjects
MYOCARDIAL injury ,MYOCARDIAL infarction ,SCIENTIFIC literature ,CARDIAC surgery ,HEART injuries ,ATHLETES ,ENDURANCE athletes - Abstract
Open in new tab Download slide Open in new tab Download slide OBJECTIVES Cardiac biomarkers are indicators of irreversible cell damage. Current myocardial infarction (MI) definitions require concomitant clinical characteristics. For perioperative MI, a correlation of biomarker elevations and mortality has been suggested. Definitions emerged relying on cardiac biomarker release only. This approach is questionable as several clinical and experimental scenarios exist where relevant biomarker release can occur apart from MI. METHODS We reviewed the clinical and basic science literature and revealed important aspects regarding the use and interpretation of cardiac biomarker release with special focus on their interpretation in the perioperative setting. RESULTS Ischaemic biomarkers may be released without cell death in multiple conditions, such as after endurance runs in athletes, temporary inotropic stimulation in animal models and flow variations in in vitro cell models. In addition, access through atrial tissue during cannulation or concomitant valve procedures adds sources of enzyme release that may not be related to ventricular ischaemia (i.e. MI). Such non-cell death-related mechanisms may explain the lack of poor correlations of enzyme release and long-term outcomes in recent trials. In addition, the 3 main biomarkers, troponin T, I and creatine kinase myocardial band, differ in their release kinetics, which may differentially trigger MI events in trial patients. CONCLUSIONS The identification of irreversible myocardial injury in cardiac surgery based only on biomarker release is unreliable. Cell death- and non-cell death-related mechanisms create a mix in the perioperative setting that requires additional markers for proper identification of MI. In addition, the 3 most common ischaemic biomarkers display different release kinetics adding to the confusion. We review the topic. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Does Preoperative Sinus Rhythm Influence Surgical Ablation's Perioperative Safety in Patients with Atrial Fibrillation?
- Author
-
Vondran, Maximilian, Ghazy, Tamer, Albert, Marc, Warnecke, Henning, Doss, Mirko, Liebold, Andreas, Eszlari, Edgar, Caliskan, Etem, Ouarrak, Taoufik, Doll, Nicolas, Senges, Jochen, Hanke, Thorsten, and Rastan, Ardawan J.
- Published
- 2021
- Full Text
- View/download PDF
13. Conventional versus minimally invasive extracorporeal circulation in patients undergoing cardiac surgery: protocol for a randomised controlled trial (COMICS).
- Author
-
Angelini, Gianni D, Reeves, Barnaby C, Evans, Jonathan, Culliford, Lucy A, Collett, Laura, Rogers, Chris A, Stokes, Elizabeth, Anastasiadis, Kyriakos, Antonitsis, Polychronis, Carrel, Thierry, Keller, Dorothée, Liebold, Andreas, Ashkanani, Fatma, El-Essawi, Aschraf, Breitenbach, Ingo, Lloyd, Clinton, Bennett, Mark, Cale, Alex, Mclean, Lindsay, and Gunaydin, Serdar
- Subjects
PREVENTION of surgical complications ,ARTIFICIAL blood circulation ,CARDIAC surgery ,ENDOSCOPIC surgery ,RANDOMIZED controlled trials ,DESCRIPTIVE statistics ,COST effectiveness ,RESEARCH funding - Abstract
Introduction: Despite low mortality, cardiac surgery patients may experience serious life-threatening post-operative complications, often due to extracorporeal circulation and reperfusion. Miniaturised cardiopulmonary bypass (minimally invasive extracorporeal circulation) has been developed aiming to reduce the risk of post-operative complications arising with conventional extracorporeal circulation. Methods: The COMICS trial is a multi-centre, international, two-group parallel randomised controlled trial testing whether type II, III or IV minimally invasive extracorporeal circulation is effective and cost-effective compared to conventional extracorporeal circulation in patients undergoing elective or urgent coronary artery bypass grafting, aortic valve replacement or coronary artery bypass grafting + aortic valve replacement. Randomisation (1:1 ratio) is concealed and stratified by centre and surgical procedure. The primary outcome is a composite of 12 serious complications, objectively defined or adjudicated, 30 days after surgery. Secondary outcomes (at 30 days) include other serious adverse events (primary safety outcome), use of blood products, length of intensive care and hospital stay and generic health status (also at 90 days). Status of the trial: Two centres started recruiting on 08 May 2018; 10 are currently recruiting and 603 patients have been randomised (11 May 2020). The recruitment rate from 01 April 2019 to 31 March 2020 was 40-50 patients/month. About 80% have had coronary artery bypass grafting only. Adherence to allocation is good. Conclusions: The trial is feasible but criteria for progressing to a full trial were not met on time. The Trial Steering and Data Monitoring Committees have recommended that the trial should currently continue. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
14. Impact of pre-existing comorbidities on outcomes of patients undergoing surgical aortic valve replacement - rationale and design of the international IMPACT registry.
- Author
-
Bakhtiary, Farhad, Ahmad, Ali El-Sayed, Autschbach, Rüdiger, Benedikt, Peter, Bonaros, Nikolaos, Borger, Michael, Dewald, Oliver, Feyrer, Richard, Geißler, Hans-Joachim, Grünenfelder, Jürg, Lam, Ka Yan, Leyh, Rainer, Liebold, Andreas, Czesla, Markus, Mehdiani, Arash, Pollari, Francesco, Salamate, Saad, Strauch, Justus, Vötsch, Andreas, and Weber, Alberto
- Subjects
AORTIC valve transplantation ,AORTIC valve diseases ,CORONARY artery bypass ,OPERATIVE surgery ,PATIENT selection ,HEART valve prosthesis implantation ,AORTIC valve surgery ,EXPERIMENTAL design ,RESEARCH ,INFLAMMATION ,RESEARCH methodology ,ACQUISITION of data ,AORTIC stenosis ,MEDICAL cooperation ,EVALUATION research ,TREATMENT effectiveness ,COMPARATIVE studies ,PROSTHETIC heart valves ,IMPACT of Event Scale ,RESEARCH funding ,HEMODYNAMICS ,COMORBIDITY ,LONGITUDINAL method - Abstract
Background: Degenerative aortic valve disease accounts for 10-20% of all cardiac surgical procedures. The impact of pre-existing comorbidities on the outcome of patients undergoing surgical aortic valve replacement (SAVR) needs further research.Methods: The IMPACT registry is a non-interventional, prospective, open-label, multicenter, international registry with a follow-up of 5 years to assess the impact of pre-existing comorbidities of patients undergoing SAVR with the INSPIRIS RESILIA aortic valve on outcomes. IMPACT will be conducted across 25 sites in Austria, Germany, The Netherlands and Switzerland and intends to enroll approximately 500 patients. Patients will be included if they are at least 18 years of age and are scheduled to undergo SAVR with the INSPIRIS RESILIA Aortic Valve with or without concomitant ascending aortic root replacement and/or coronary bypass surgery. The primary objective is to determine all-cause mortality at 1, 3, and 5 years post SAVR. Secondary objectives include cardiac-related and valve-related mortality and structural valve deterioration including hemodynamics and durability, valve performance and further clinical outcomes in the overall study population and in specific patient subgroups characterized by the presence of chronic kidney disease, hypertension, metabolic syndrome and/or chronic inflammation.Discussion: IMPACT is a prospective, multicenter European registry, which will provide much-needed data on the impact of pre-existing comorbidities on patient outcomes and prosthetic valve performance, and in particular the performance of the INSPIRIS RESILIA, in a real-world setting. The findings of this study may help to support and expand appropriate patient selection for treatment with bioprostheses.Trial Registration: ClinicalTrials.gov identifier: NCT04053088 . [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
15. Non-invasive determination of pressure recovery by cardiac MRI and echocardiography in patients with severe aortic stenosis: short and long-term outcome prediction.
- Author
-
Sagmeister, Florian, Herrmann, Sebastian, Gassenmaier, Tobias, Bernhardt, Peter, Rasche, Volker, Liebold, Andreas, Weidemann, Frank, Brunner, Horst, and Beer, Meinrad
- Published
- 2020
- Full Text
- View/download PDF
16. Hemoadsorption treatment with CytoSorb® in patients with extracorporeal life support therapy: A case series.
- Author
-
Träger, Karl, Skrabal, Christian, Fischer, Guenther, Schroeder, Janpeter, Marenski, Larissa, Liebold, Andreas, Reinelt, Helmut, and Datzmann, Thomas
- Published
- 2020
- Full Text
- View/download PDF
17. Pericardial fluids or Cardiopulmonary Bypass—Is There a Major Culprit for Changes in Coagulation and Inflammation?
- Author
-
Gorki, Hagen, Nakamura, Julia, Kunert, Andreas, Hoenicka, Markus, and Liebold, Andreas
- Subjects
CARDIOPULMONARY bypass ,BLOOD coagulation ,MYOCARDIAL revascularization ,FLUIDS ,INTENSIVE care units - Abstract
Background From the results of a previous study, it remained to be investigated if a perioperative rise of few tested coagulation and inflammation markers is caused by conventional cardiopulmonary bypass (CPB) itself or rather by direct recirculation of pericardial fluids. Methods Forty-eight patients operated on with conventional CPB for myocardial revascularization were randomized either for direct recirculation of pericardial suction fluids or for cell saving (CS). Results Thrombin–antithrombin complexes showed lower values intraoperatively in the CS group (p < 0.0001), and D-dimers tended to remain lower at intensive care unit arrival (p = 0.095). Tests of inflammation markers were less meaningful. Conclusion Direct recirculation of pericardial fluids rather than conventional CPB itself causes major intraoperative changes of some coagulation markers. Pericardial blood loss with direct recirculation should be kept to a minimum to avoid unnecessary activation of coagulation. Inflammation markers need further investigations. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
18. Hemodynamic energy during pulsatile extracorporeal circulation using flexible and rigid arterial tubing: a reassessment.
- Author
-
Dürr, Anke, Kunert, Andreas, Albrecht, Günter, Liebold, Andreas, and Hoenicka, Markus
- Subjects
BLOOD circulation ,ARTERIES ,BIOLOGICAL models ,ARTIFICIAL blood circulation ,BLOOD pressure ,COMPUTER software ,ENDOSCOPIC surgery ,ENERGY transfer ,HEMODYNAMICS ,MATERIALS testing ,PERFUSION ,PROBABILITY theory ,SILICONES ,STATISTICS ,DATA analysis ,DESCRIPTIVE statistics ,EVALUATION ,PHYSIOLOGY - Abstract
Introduction: Pulsatile extracorporeal circulation may improve organ perfusion during cardiac surgery. Some minimally invasive extracorporeal circulation (MiECC) systems allow pulsatile perfusion. The present study investigated the influence of arterial tubing compliance on hemodynamic energy transfer into the patient. Methods: Aortic models with adult human geometry were perfused in a mock circulation. A MiECC system was connected using either high-compliance silicone tubing or standard kit tubing. Energy equivalent pressure (EEP) and surplus hemodynamic energy (SHE) were computed from flow and pressure data. Aortic models with physiological and sub-physiological compliance were tested to assess the influence of the pseudo-patient. Results: Non-pulsatile flow did not generate SHE. SHE during pulsatile flow in the compliant aortic model was significantly higher with kit tubing compared to silicone tubing. Maximum SHE was achieved at 1.6 L/min with kit tubing (7.7% of mean arterial pressure) and with silicone tubing (4.9%). Using the low-compliance aortic model, SHE with kit tubing reached a higher maximum of 14.2% at 1.8 L/min compared to silicone tubing (11.8% at 1.5 L/min). Conclusions: Flexible arterial tubing did not preserve more hemodynamic energy from a pulsatile pump compared to standard kit tubing in a model of adult extracorporeal circulation. The pseudo-patient's compliance significantly affected the properties of the mock circulation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
19. Fulminante Lungenarterienembolie bei heparininduzierter Thrombozytopenie Typ II.
- Author
-
Brück, Simone, Skrabal, Christian, Liebold, Andreas, Mols, Georg, and Träger, Karl
- Published
- 2019
- Full Text
- View/download PDF
20. Effect of the analgesic metamizole (dipyrone) on volume balance and vasopressor use in cardiac surgery patients.
- Author
-
HOENICKA, Markus, STAHL, Luisa, DATZMANN, Thomas, MAYER, Benjamin, OMAJ, Qefsim, LIEBOLD, Andreas, and TRÄGER, Karl
- Published
- 2022
- Full Text
- View/download PDF
21. Nonrobotic Total Endoscopic Coronary Artery Bypass Grafting: A Proof-of-Concept Study in 20 Patients.
- Author
-
Gorki, Hagen, Jun Liu, Sabau, Marius, Albrecht, Guenther, and Liebold, Andreas
- Published
- 2018
- Full Text
- View/download PDF
22. Assessment and pathophysiology of pain in cardiac surgery.
- Author
-
Zubrzycki, Marek, Liebold, Andreas, Skrabal, Christian, Reinelt, Helmut, Ziegler, Mechthild, Perdas, Ewelina, and Zubrzycka, Maria
- Subjects
PATHOLOGICAL physiology ,CARDIAC surgery ,POSTOPERATIVE pain ,ANALGESICS ,IMMUNOSUPPRESSION - Abstract
Analysis of the problem of surgical pain is important in view of the fact that the success of surgical treatment depends largely on proper pain management during the first few days after a cardiosurgical procedure. Postoperative pain is due to intraoperative damage to tissue. It is acute pain of high intensity proportional to the type of procedure. The pain is most intense during the first 24 hours following the surgery and decreases on subsequent days. Its intensity is higher in younger subjects than elderly and obese patients, and preoperative anxiety is also a factor that increases postoperative pain. Ineffective postoperative analgesic therapy may cause several complications that are dangerous to a patient. Inappropriate postoperative pain management may result in chronic pain, immunosuppression, infections, and less effective wound healing. Understanding and better knowledge of physiological disorders and adverse effects resulting from surgical trauma, anesthesia, and extracorporeal circulation, as well as the development of standards for intensive postoperative care units are critical to the improvement of early treatment outcomes and patient comfort. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
23. Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats.
- Author
-
Zubrzycki, Marek, Janecka, Anna, Liebold, Andreas, Ziegler, Mechthild, and Zubrzycka, Maria
- Subjects
OROFACIAL pain ,CANNABINOIDS ,OPIOIDS ,ANALGESIA ,DRUG administration ,DRUG dosage ,AMIDASES ,ANALGESICS ,ANIMAL experimentation ,BIOLOGICAL models ,CEREBRAL ventricles ,CELL receptors ,COMPARATIVE studies ,DRUGS ,ESTERASES ,FACIAL pain ,RESEARCH methodology ,MEDICAL cooperation ,NARCOTICS ,NEUROTRANSMITTERS ,PAIN ,RATS ,RESEARCH ,EVALUATION research ,CHEMICAL inhibitors ,PHARMACODYNAMICS - Abstract
Background and Purpose: Endocannabinoids and opioids play a vital role in mediating pain-induced analgesia. The specific effects of these compounds within the orofacial region are largely unknown. In this study, we tried to determine whether an increase in cannabinoid and opioid concentration in the CSF affects impulse transmission between the motor centres localized in the vicinity of the third and fourth cerebral ventricles.Experimental Approach: The study objectives were realized on rats using a method that allows the recording of the amplitude of evoked tongue jerks (ETJ) in response to noxious tooth pulp stimulation. The amplitude of ETJ was a measure of the effect of neurotransmitters on neural structures.Key Results: Perfusion of cerebral ventricles with anandamide (AEA), endomorphin-2 (EM-2), URB597, an inhibitor of fatty acid amide hydrolase (FAAH) and JZL195, a dual inhibitor of FAAH and monoacylglycerol lipase (MAGL) reduced the ETJ amplitude. The antinociceptive effect of AEA, EM-2, URB597 and JZL195 was blocked by CB1 receptor antagonist, AM251 and by μ receptor-antagonist, β-funaltrexamine. In contrast to AEA, 2-arachidonoylglycerol alone did not decrease ETJ amplitude.Conclusions and Implications: We demonstrated that in the orofacial area, analgesic activity is modulated by AEA and that EM-2-induced antinociception was mediated by μ and CB1 receptors. The action of AEA and EM-2 is tightly regulated by FAAH and FAAH/MAGL, by preventing the breakdown of endogenous cannabinoids in regions where they are produced on demand. Therefore, the current findings support the therapeutic potential of FAAH and FAAH/MAGL inhibitors as novel pharmacotherapeutic agents for orofacial pain. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
24. Contact-free monitoring of vessel graft stiffness - proof of concept as a tool for vascular tissue engineering.
- Author
-
Hoenicka, Markus, Kaspar, Marcel, Schmid, Christof, Liebold, Andreas, and Schrammel, Siegfried
- Published
- 2017
- Full Text
- View/download PDF
25. Influence of Cannulation Site on Carotid Perfusion During Extracorporeal Membrane Oxygenation in a Compliant Human Aortic Model.
- Author
-
Geier, Andreas, Kunert, Andreas, Albrecht, Günter, Liebold, Andreas, and Hoenicka, Markus
- Abstract
Blood oxygenized by veno-arterial extracorporeal membrane oxygenation (ECMO) can be returned to the aorta (central cannulation) or to peripheral arteries (axillar, femoral). Hemodynamic effects of these cannulation types were analyzed in a mock loop with an aortic model representative of normal anatomy and compliance under physiological pressures and flow rates. Pressures, flow rates, and contribution of ECMO flow to total flow as a measure of oxygen supply were monitored in the carotids. Steady or pulsatile ECMO flow, residual or no cardiac output, and intraaortic balloon pump counterpulsation were tested as independent factors. With residual heart function, central cannulation provided the best oxygenated flow and pressure to the carotid arteries (CA). Axillar cannulation preferentially perfused the right CA at the expense of the left CA. Femoral cannulation provided only lower amounts of oxygenated blood to both CA. Pulsation increased the surplus hemodynamic energy. Counterpulsation reduced flow with femoral cannulation but improved flow and pressure with axillar cannulation. Femoral cannulation failed to provide oxygenated blood to coronary and supraaortic arteries with residual heart function. Central cannulation provided the best hemodynamics and oxygen supply to the brain. With a resting heart but not with an ejecting heart, pulsatile ECMO flow enhanced CA hemodynamics. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
26. Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass - a case series.
- Author
-
Träger, Karl, Skrabal, Christian, Fischer, Guenther, Datzmann, Thomas, Schroeder, Janpeter, Fritzler, Daniel, Hartmann, Jan, Liebold, Andreas, and Reinelt, Helmut
- Published
- 2017
- Full Text
- View/download PDF
27. Selective venous vasodilator properties of the analgesic metamizole (dipyrone) in a human ex vivo model-implications for postoperative pain management.
- Author
-
Hoenicka, Markus, Gorki, Hagen, Traeger, Karl, and Liebold, Andreas
- Abstract
Metamizole (dipyrone) is a first-line, non-opioid analgesic used for postoperative pain management. Clinical data and animal experiments indicate a possible vasodilator action of this drug. We investigated the effects of metamizole on human artery and vein tone in an ex vivo model to assess potential contributions to venous pooling. Excess segments of bypass grafts were harvested during coronary artery bypass grafting procedures. Tensions were measured in an organ bath for 120 min after adding metamizole to the preconstricted vessels. Contribution of endothelium was assessed in endothelium-denuded vessels, and indometacin was used to identify cyclooxygenase-mediated effects. Internal mammary arteries ( n = 6) constricted after addition of 1, 3, and 10 μM metamizole and remained constricted at the lower doses. Transient constrictions also occurred in saphenous veins ( n = 20), but veins relaxed below solvent controls after 20 min at all concentrations. Endothelium removal ( n = 12) and cyclooxygenase inhibition ( n = 12) suppressed the vasoconstrictor effect but not the vasodilator effect. Metamizole and its metabolites display counteracting effects on blood vessel tone ex vivo. The vasoconstrictor effect is mediated by cyclooxygenase-derived products. The net effect is site-specific, resulting in a selective venous vasodilator action. This may exacerbate unwanted venous pooling during postoperative pain therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
28. Similarity of coagulation and inflammation despite different surgical revascularization strategies – a prospective randomized trial.
- Author
-
Gorki, Hagen, Hoenicka, Markus, Rupp, Patricia, Müller-Eising, Kristina, Deininger, Stefanie, Kunert, Andreas, and Liebold, Andreas
- Subjects
ANALYSIS of variance ,BIOMARKERS ,BLOOD coagulation ,BLOOD coagulation factors ,C-reactive protein ,CHI-squared test ,CORONARY artery bypass ,EXTRACORPOREAL membrane oxygenation ,INFLAMMATION ,LONGITUDINAL method ,STATISTICAL sampling ,RANDOMIZED controlled trials ,REVASCULARIZATION (Surgery) ,DESCRIPTIVE statistics ,KRUSKAL-Wallis Test - Abstract
Background: Supposedly, minimized extracorporeal circulation or off-pump revascularization as alternatives to conventional extracorporeal circulation (ONCAB) reduce inflammation and coagulation disturbances. Methods: One hundred and twenty coronary artery bypass graft (CABG) patients were prospectively randomized for three surgical techniques. Coagulation and inflammation markers were measured up to 72 hours postoperatively. Results: Coagulation factors I, II, V, X, antithrombin III and C-reactive protein did not differ perioperatively between the groups and increased, as did several other markers, 12 to 72 hours postoperatively. Compared to its alternatives, ONCAB showed the most obvious transient increase in thrombin-antithrombin complexes (p<0.0001), D-dimers (p=0.0059), tissue factor pathway inhibitor (p=0.0005), factor VIII (p=0.0041) and tumor necrosis factor α (p=0.0300) during the operation and up to 12 hours postoperatively. Furthermore, ONCAB generated lower leukocyte and platelet counts and higher values of soluble P-selectin and soluble intercellular adhesion molecule 1 at some time points. Conclusions: With similarity in pivot coagulation factors, a specific detrimental influence of ONCAB on common coagulation pathways was excluded. Higher perioperative concentrations of products from the coagulation cascade most likely indicate activation of pericardial blood – recirculated only in ONCAB. Furthermore, with only temporary differences in markers of inflammation, the alternatives to ONCAB altogether were without advantage at 72 hours postoperatively. In the general answer to surgical trauma, the part of modern extracorporeal circulation is possibly overestimated. The study is registered at the German Clinical Trial Registry. Registration number DRKS00007580. URL: https://drks-neu.uniklinik-freiburg.de/drks_web/ URL: http://apps.who.int/trialsearch/ [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
29. Renal Function and Urinary Biomarkers in Cardiac Bypass Surgery: A Prospective Randomized Trial Comparing Three Surgical Techniques.
- Author
-
Deininger, Stefanie, Hoenicka, Markus, Müller-Eising, Kristina, Rupp, Patricia, Liebold, Andreas, Koenig, Wolfgang, and Gorki, Hagen
- Subjects
OPERATIVE surgery ,SURGICAL complications ,CARDIOPULMONARY bypass ,ARTIFICIAL blood circulation ,GLOMERULAR filtration rate - Abstract
Background Cardiopulmonary bypass procedure is associated with an increased risk of renal impairment. To which extent structural damage causes functional decline is unknown. We evaluated perioperative kidney injury and function in patients treated with conventional extracorporeal circulation (CECC), minimized extracorporeal circulation (MECC), and off-pump coronary artery bypass grafting (OPCAB). Methods Blood and urine samples, collected at baseline and up to 72 hours after surgery from patients of the HEPCON trial (DRKS00007580, 120 patients randomized for heparin management and for surgical technique), were analyzed for differences in renal injury and function. Neutrophil gelatinase-associated lipocalin, α glutathione S-transferase, liver fatty acid-binding protein, and kidney injury molecule-1 were measured as urinary protein markers of renal tubular injury. Serum creatinine, blood urea levels, and estimated glomerular filtration rate were determined to monitor renal function. Results Markers of tubular injury differed significantly between surgical technique groups early after surgery, indicating the most detrimental effect in CECC. Hemolysis and hemodilution correlated with these early changes. A late rise did not show intergroup differences. Time courses of renal function parameters, as well as the development of acute kidney injury in 15 patients (13.5%), were irrespective of surgical technique. Heparin management did not influence renal parameters. Conclusion During coronary artery bypass grafting, CECC temporarily induces more tubular injury thanMECC or OPCAB. However, late changes of renal function parameters occur irrespective of extracorporeal perfusion mode and even in off-pump surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
30. Use of minimal invasive extracorporeal circulation in cardiac surgery: principles, definitions and potential benefits. A position paper from the Minimal invasive Extra-Corporeal Technologies international Society (MiECTiS).
- Author
-
Anastasiadis, Kyriakos, Murkin, John, Antonitsis, Polychronis, Bauer, Adrian, Ranucci, Marco, Gygax, Erich, Schaarschmidt, Jan, Fromes, Yves, Philipp, Alois, Eberle, Balthasar, Punjabi, Prakash, Argiriadou, Helena, Kadner, Alexander, Jenni, Hansjoerg, Albrecht, Guenter, Boven, Wim van, Liebold, Andreas, Somer, Fillip de, Hausmann, Harald, and Deliopoulos, Apostolos
- Published
- 2016
- Full Text
- View/download PDF
31. On-Pump Nonrobotic Total Endoscopic Coronary Artery Bypass Grafting: An Animal Study.
- Author
-
Gorki, Hagen, Jun Liu, Poelzing, Frank, Gorki, Susanne D., Pasche, Heidi, Albrecht, Guenter, and Liebold, Andreas
- Subjects
CORONARY artery bypass ,ENDOSCOPIC surgery ,LABORATORY swine ,SUTURES ,SURGICAL anastomosis - Abstract
Background Total endoscopic coronary artery bypass grafting (TECAB) is currently performed exclusively with the help of a telemanipulator. After extensive practice in a biomechanical model, the operation was performed as a nonrobotic approach in an animal study. Methods Six large domestic pigs were anesthetized and intubated. Port access and endoscopic vision were used exclusively during the intrathoracic procedure. In five animals, an internal mammary artery was harvested, extracorporeal circulation was established via peripheral vessel access, and the ascending aorta occluded with an intraluminal balloon. In cardioplegic arrest, an anastomosis of internal mammary artery and left anterior descending coronary artery was performed with shortened 7-0 monofil thread running suture. As a terminal study, the animals were humanely killed and the quality of the anastomoses was checked. Results After a steady learning curve, the fifth animal was operated on successfully and a satisfactory anastomosis was documented. Conclusion Despite demanding differences to humans as shape of thoracic cavity and size of peripheral access vessels, the viability of the nonrobotic TECAB concept was documented in a living animal model. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
32. Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series.
- Author
-
Träger, Karl, Fritzler, Daniel, Fischer, Guenther, Schröder, Janpeter, Skrabal, Christian, Liebold, Andreas, and Reinelt, Helmut
- Published
- 2016
- Full Text
- View/download PDF
33. Cytokine Reduction in the Setting of an ARDS-Associated Inflammatory Response with Multiple Organ Failure.
- Author
-
Träger, Karl, Schütz, Christian, Fischer, Günther, Schröder, Janpeter, Skrabal, Christian, Liebold, Andreas, and Reinelt, Helmut
- Subjects
ADULT respiratory distress syndrome ,CYTOKINES ,MULTIPLE organ failure ,INFLAMMATION ,HOSPITAL admission & discharge ,MIDDLE-aged men ,SMALL intestine diseases ,HEALTH - Abstract
A 45-year-old male was admitted to our hospital with a small bowel obstruction due to torsion and was immediately scheduled for surgical intervention. At anesthesia induction, the patient aspirated and subsequently developed a severe SIRS with ARDS and multiple organ failure requiring the use of ECMO, CRRT, antibiotics, and low dose steroids. Due to a rapid deterioration in clinical status and a concurrent surge in inflammatory biomarkers, an extracorporeal cytokine adsorber (CytoSorb) was added to the CRRT blood circuit. The combined treatment resulted in a rapid and significant reduction in the levels of circulating inflammatory mediators. This decrease was paralleled by marked clinical stabilization of the patient including a significant improvement in hemodynamic stability and a reduced need for norepinephrine and improved respiratory function as measured by PaO
2 /FIO2 , ventilator parameters, lung mechanics, and indirect measures of capillary leak syndrome. The patient could be discharged to a respiratory weaning unit where successful respiratory weaning could be achieved later on. We attribute the clinical improvement to the rapid control of the hyperinflammatory response and the reduction of inflammatory mediators using a combination of CytoSorb and these other therapies. CytoSorb treatment was safe and well tolerated, with no device-related adverse effects observed. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
34. Combination of Sildenafil and Bosentan for Pulmonary Hypertension in a Human Ex Vivo Model.
- Author
-
Ried, Michael, Potzger, Tobias, Neu, Reiner, Sziklavari, Zsolt, Szöke, Tamas, Liebold, Andreas, Hofmann, Hans-Stefan, and Hoenicka, Markus
- Abstract
Purpose: Both sildenafil and bosentan have been used clinically to treat pulmonary arterial hypertension. As these substances target different pathways to modulate vasoconstriction, we investigated the combined effects of both drug classes in isolated human pulmonary vessels. Methods: Segments of pulmonary arteries (PA) and veins (PV) were harvested from 51 patients undergoing lobectomy. Contractile force was determined isometrically in an organ bath. Vessels were constricted with norepinephrine (NE) to determine effects of sildenafil. They were constricted with ET-1 to assess effects of bosentan, and with NE and ET-1 to evaluate the combination of both substances. Results: Sildenafil (1E-5 M) significantly reduced maximum constriction by NE of both PA (13.0 ± 11.1 vs. 34.9 ± 7.6 % relative to KCl induced constriction; n = 6; p < 0.001) and PV (81.2 ± 34.2 vs 121.6 ± 20.8 %; n = 6; p < 0.01) but did not affect basal tones. Bosentan (1E-5 M) significantly reduced maximum constriction of PV (56.6 ± 21.5 vs. 172.1 ± 30.0 %; n = 6; p < 0.01) by ET-1 and led to a small but insignificant decrease of basal tone ( p = 0.07). Bosentan almost completely abolished constriction of PA (1.0 ± 0.9 vs. 74.7 ± 25.7 %; n = 6; p < 0.001) by ET-1, but did not affect basal tone. Bosentan (1E-7 M) significantly attenuated combined ET-1/NE dose-response curves in PA (93.1 ± 47.4 vs. 125.3 ± 41.0 %; n = 12; p < 0.001) whereas the effect of sildenafil (1E-5 M) was less pronounced (103.6 ± 20.2 %; p < 0.05). Simultaneous administration of both substances showed a significantly greater reduction of maximum constriction in PA compared to individual administration (64.6 ± 26.3 %; p < 0.001). Conclusions: Sildenafil only at its highest concentration was effective in suppressing NE induced pulmonary vessel contraction. Bosentan was able to completely suppress ET-1 induced contraction of PA and strongly attenuated contraction of PV. The present data suggest a benefit of sildenafil/bosentan combination therapy as they affect different pathways and may allow lower dosages. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
35. A Step Toward Nonrobotic Total Endoscopic Coronary Bypass Grafting.
- Author
-
Gorki, Hagen, Patel, Nirav C., Liewald, Christian, Wildhirt, Stephen, Subramanian, Valavanur A., and Liebold, Andreas
- Published
- 2012
- Full Text
- View/download PDF
36. Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients.
- Author
-
Wang, Weiwei, Li, Wenzhong, Ou, Lailiang, Flick, Eva, Mark, Peter, Nesselmann, Catharina, Lux, Cornelia A., Gatzen, Hans-Heinrich, Kaminski, Alexander, Liebold, Andreas, Lützow, Karola, Lendlein, Andreas, Li, Ren-Ke, Steinhoff, Gustav, and Ma, Nan
- Subjects
MESENCHYMAL stem cells ,GENETIC transformation ,BONE marrow cells ,STEM cell transplantation ,GENE therapy ,STEM cell treatment ,MYOCARDIAL infarction ,CARDIAC regeneration ,POLYETHYLENE - Abstract
Transplantation of mesenchymal stem cells (MSCs) derived from adult bone marrow has been proposed as a potential therapeutic approach for post-infarction left ventricular (LV) dysfunction. However, age-related functional decline of stem cells has restricted their clinical benefits after transplantation into the infarcted myocardium. The limitations imposed on patient cells could be addressed by genetic modification of stem cells. This study was designed to improve our understanding of genetic modification of human bone marrow derived mesenchymal stem cells (hMSCs) by polyethylenimine (PEI, branched with Mw 25 kD), one of non-viral vectors that show promise in stem cell genetic modification, in the context of cardiac regeneration for patients. We optimized the PEI-mediated reporter gene transfection into hMSCs, evaluated whether transfection efficiency is associated with gender or age of the cell donors, analysed the influence of cell cycle on transfection and investigated the transfer of therapeutic vascular endothelial growth factor gene (VEGF). hMSCs were isolated from patients with cardiovascular disease aged from 41 to 85 years. Optimization of gene delivery to hMSCs was carried out based on the particle size of the PEI/DNA complexes, N/P ratio of complexes, DNA dosage and cell viability. The highest efficiency with the cell viability near 60% was achieved at N/P ratio 2 and 6.0 μg DNA/cm
2 . The average transfection efficiency for all tested samples, middle-age group (<65 years), old-age group (>65 years), female group and male group was 4.32%, 3.85%, 4.52%, 4.14% and 4.38%, respectively. The transfection efficiency did not show any correlation either with the age or the gender of the donors. Statistically, there were two subpopulations in the donors; and transfection efficiency in each subpopulation was linearly related to the cell percentage in S phase. No significant phenotypic differences were observed between these two subpopulations. Furthermore, PEI-mediated therapeutic gene VEGF transfer could significantly enhance the expression level. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
37. Intracardiac injection of matrigel induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model.
- Author
-
Ou, Lailiang, Li, Wenzhong, Zhang, Yue, Wang, Weiwei, Liu, Jun, Sorg, Heiko, Furlani, Dario, Gäbel, Ralf, Mark, Peter, Klopsch, Christian, Wang, Liang, Lützow, Karola, Lendlein, Andreas, Wagner, Klaus, Klee, Doris, Liebold, Andreas, Li, Ren-Ke, Kong, Deling, Steinhoff, Gustav, and Ma, Nan
- Subjects
INJECTIONS ,STEM cells ,HEART function tests ,MYOCARDIAL infarction ,LABORATORY rats ,MYOCARDIUM ,LEFT heart ventricle ,VENTRICULAR remodeling - Abstract
Matrigel promotes angiogenesis in the myocardium from ischemic injury and prevents remodelling of the left ventricle. We assessed the therapeutic efficacy of intracardiac matrigel injection and matrigel-mediated stem cell homing in a rat myocardial infarction (MI) model. Following MI, matrigel (250 μl) or phosphate-buffered solution (PBS) was delivered by intracardiac injection. Compared to the MI control group (MI-PBS), matrigel significantly improved left ventricular function ( n= 11, P < 0.05) assessed by pressure-volume loops after 4 weeks. There is no significant difference in infarct size between MI-matrigel (MI-M; 21.48 ± 1.49%, n= 10) and MI-PBS hearts (20.98 ± 1.25%, n= 10). The infarct wall thickness of left ventricle is significantly higher ( P < 0.01) in MI-M (0.72 ± 0.02 mm, n= 10) compared with MI-PBS (0.62 ± 0.02 mm, n= 10). MI-M hearts exhibited higher capillary density (border 130.8 ± 4.7 versus 115.4 ± 6.0, P < 0.05; vessels per high-power field [HPF; 400×], n= 6) than MI-PBS hearts. c-Kit stem cells (38.3 ± 5.3 versus 25.7 ± 1.5 c-Kit cells per HPF [630×], n= 5, P < 0.05) and CD34 cells (13.0 ± 1.51 versus 5.6 ± 0.68 CD34 cells per HPF [630×], n= 5, P < 0.01) were significantly more numerous in MI-M than in MI-PBS in the infarcted hearts ( n= 5, P < 0.05). Intracardiac matrigel injection restores myocardial functions following MI, which may attribute to the improved recruitment of CD34 and c-Kit stem cells. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
38. Localized SDF-1alpha gene release mediated by collagen substrate induces CD117+ stem cells homing.
- Author
-
Weiwei Wang, Wenzhong Li, Lee-Lee Ong, Furlani, Dario, Kaminski, Alexander, Liebold, Andreas, Lützow, Karola, Lendlein, Andreas, Jun Wang, Ren-Ke Li, Steinhoff, Gustav, and Nan Ma
- Subjects
STEM cells ,COLLAGEN ,DNA ,PLASMIDS ,AMINES - Abstract
Stromal cell-derived factor-1α (SDF-1α) mediated mobilization and homing of stem cells showed promising potential in stem cell based tissue engineering and regenerative medicine. However local and sustained release of SDF-1α is indispensable for stem cell mediated regenerative process due to its short half-life under inflammatory conditions. In this study, a gene activated collagen substrate (GAC) was formed via assembly of plasmid encoding SDF-1α into a collagen substrate to create a microenvironment favoring stem cell homing. Local release of SDF-1α from the transfected cells on GAC and its effect on CD117
+ stem cell homing were investigated. Non-viral poly-ethyleneimine (25kDa PEI)/DNA complexes were mixed with rat tail collagen solution to form the GAC. Optimization of GAC was carried out based on collagen effects on the PEI/DNA complexes, viability and luciferase expression of COS7 cells on GAC. CD117+ stem cells homing in response to SDF-1α local expression from transfected cells on GAC were investigated in a flow chamber in vitro and in a mouse hind limb model in vivo. The gene expression, migration of CD117+ stem cells and the induced inflammation were investigated with immunostaining, reverse transcription polymerase chain reaction (RT-PCR) and H&E staining. The optimized parameters for GAC were DNA dosage 10 μg/cm2 , molar ratio of PEI nitrogen in primary amine to DNA phosphate (N/P ratio) 4 and mass ratio of collagen to DNA (C/D ratio) 1.0. It kept cell viability above 75% and transfection efficiency around 5.8 × 105 RLU/mg protein. GAC allowed the sustained gene release up to 60 days. GAC mediated SDF-1α gene release induced migration and homing of CD117+ stem cells in vitro and in vivo significantly, and the inflammation of GAC reduced significantly two weeks after transplantation. GAC is a promising stem cell based therapeutic strategy for regenerative medicine. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
39. Otolog kök hücre tedavisi ve cerrahi miyokardiyal revaskülarizasyon - Rostock Universitesi tecrübesi.
- Author
-
Yerebakan C, Ugurlucan M, Kaminski A, Westphal B, Liebold A, Steinhoff G, Yerebakan, Can, Uğurlucan, Murat, Kaminski, Alexander, Westphal, Bernd, Liebold, Andreas, and Steinhoff, Gustav
- Abstract
Copyright of Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2009
40. Otolog kök hücre tedavisi ve cerrahi miyokardiyal revaskülarizasyon - Rostock Üniversitesi tecrübesi.
- Author
-
Yerebakan, Can, Uğurlucan, Murat, Kaminski, Alexander, Westphal, Bernd, Liebold, Andreas, and Steinhoff, Gustav
- Subjects
STEM cells ,CARDIOMYOPATHIES ,BONE marrow ,CLINICAL trials ,CORONARY artery bypass ,ECHOCARDIOGRAPHY - Abstract
Copyright of Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2009
41. Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting.
- Author
-
Yerebakan, Can, Kaminski, Alexander, Westphal, Bernd, Liebold, Andreas, and Steinhoff, Gustav
- Subjects
CARDIOVASCULAR diseases ,CORONARY heart disease treatment ,STEM cell treatment ,CORONARY artery bypass ,BONE marrow - Abstract
Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide. Especially the treatment of ischemic heart disease challenges physicians despite recent advances in medical and operative strategies. Due to the considerable developments in regenerative medicine cell-based treatment for ischemic heart disease has attracted great interest in the last decade. Numerous experimental and clinical approaches employing stem cell treatment from various sources and using different methods of cell delivery have shown improvement in cardiac function after acute or chronic ischemic jeopardy. In this report we will focus on our long-term experience on the safety of bone marrow derived CD133+ stem cell transplantation with concomitant coronary artery bypass surgery and provide an overview of the current knowledge on utilizing cell-based treatment for ischemic heart disease. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
42. Calcium phosphate surfaces promote osteogenic differentiation of mesenchymal stem cells.
- Author
-
Müller, Petra, Bulnheim, Ulrike, Diener, Annette, Lüthen, Frank, Teller, Marianne, Klinkenberg, Ernst-Dieter, Neumann, Hans-Georg, Nebe, Barbara, Liebold, Andreas, Steinhoff, Gustav, and Rychly, Joachim
- Subjects
CALCIUM phosphate ,OSTEOSARCOMA ,STEM cells ,BONE marrow diseases ,GENE expression ,ALKALINE phosphatase - Abstract
Although studies in vivo revealed promising results in bone regeneration after implantation of scaffolds together with osteogenic progenitor cells, basic questions remain how material surfaces control the biology of mesenchymal stem cells (MSC).We used human MSC derived from bone marrow and studied the osteogenic differentiation on calcium phosphate surfaces. In osteogenic differentiation medium MSC differentiated to osteoblasts on hydroxyapatite and BONITmatrix®, a degradable xerogel composite, within 14 days. Cells revealed a higher alkaline phosphatase (ALP) activity and increased RNA expression of collagen I and osteocalcin using real-time RTPCR compared with cells on tissue culture plastic. To test whether material surface characteristics alone are able to stimulate osteogenic differentiation, MSC were cultured on the materials in expansion medium without soluble additives for osteogenic differentiation. Indeed, cells on calcium phosphate without osteogenic differentiation additives developed to osteoblasts as shown by increased ALP activity and expression of osteogenic genes, which was not the case on tissue culture plastic. Because we reasoned that the stimulating effect on osteogenesis by calcium phosphate surfaces depends on an altered cell-extracellular matrix interaction we studied the dynamic behaviour of focal adhesions using cells transfected with GFP labelled vinculin. On BONITmatrix®, an increased mobility of focal adhesions was observed compared with cells on tissue culture plastic. In conclusion, calcium phosphate surfaces are able to drive MSC to osteoblasts in the absence of osteogenic differentiation supplements in the medium. An altered dynamic behaviour of focal adhesions on calcium phosphate surfaces might be involved in the molecular mechanisms which promote osteogenic differentiation. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
43. Effect of a miniaturized extracorporeal circulation (MECC System) on liver function.
- Author
-
Prasser, Christopher, Abbady, Mohamed, Keyl, Cornelius, Liebold, Andreas, Tenderich, Magda, Philipp, Alois, and Wiesenack, Christoph
- Subjects
ARTIFICIAL blood circulation ,CARDIOPULMONARY bypass ,ARTIFICIAL hearts ,LIVER function tests ,LIVER disease diagnosis ,PERFUSION - Abstract
Objective: To evaluate the effect of a miniaturized extracorporeal circulation system (MECC™System) compared to conventional extracorporeal circulation (ECC) regarding liver function in cardiac surgical patients. Methods: Double indicator dilution measurements were achieved by bolus injection of indocyanine green (ICG) for assessment of cardiac index (CI) and plasma disappearance rate of ICG (PDRig). Measurements were simultaneously performed preoperatively after induction of anaesthesia (T1), following admission on the ICU (T2) and 6 h postoperatively (T3). Results: CI and PDRig were markedly increased after cardiac surgery without significant differences between groups. The percentage increase in CI was significantly correlated to the percentage increase in PDRig in both groups. Conclusion: Liver function improved after cardiac surgery in both groups of patients, which may partly be explained by an increase in CI under mild inotrope support. Differences between the extracorporeal circuits with respect to PDRig appear to be minimal in a group of patients without pre-existing liver injury. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
44. Hybridtherapie bei Aneurysma verum des Aortenbogens.
- Author
-
Kische, Stephan, Ince, H�seyin, Liebold, Andreas, Rehders, Tim C., and Nienaber, Christoph A.
- Published
- 2007
- Full Text
- View/download PDF
45. Effects of poly-2-methoxyethylacrylate (PMEA)-coating on CPB circuits.
- Author
-
Skrabal, Christian A., Khosravi, Amir, Westphal, Bernd, Steinhoff, Gustav, and Liebold, Andreas
- Subjects
CARDIOPULMONARY bypass ,ARTIFICIAL blood circulation ,CARDIAC surgery ,NEUROPSYCHOLOGICAL tests ,NEUROLOGIC examination ,ETIOLOGY of diseases - Abstract
Objectives. In this study, the immuno- and neuroprotective effect of a novel cardiopulmonary bypass coating was investigated. Design. Thirty nine patients scheduled for elective coronary artery bypass grafting were randomly assigned to either PMEA-coated (n = 19) or non-coated CPB circuits (n = 20). Pericardial suction blood was separated and retransfused only if needed at the end of operation. Neurocognitive functions were examined preoperatively and 7–10 days postoperatively using a standard neuropsychological test battery. Assuming an inflammatory etiology, the most cogent inflammatory markers were perioperatively analyzed. Results. Postoperatively, patients of the PMEA-coated group performed better in Go/NoGo and Mini-Mental-test than patients of the non-coated group (p<0.04). Other neurocognitive testing did not reveal significant differences between the groups. Although most inflammatory parameters showed a significant intraindividual increase during or shortly after CPB, there was no difference in inflammatory alteration between the groups. Conclusions. PMEA-coating of cardiopulmonary bypass surfaces revealed some minor benefits in preservation of neurocognitive functions after surgery. The immediate inflammatory response remained mostly unaffected. Suction blood separation may additionally contribute to proper postoperative outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
46. Pericardial suction blood separation attenuates inflammatory response and hemolysis after cardiopulmonary bypass.
- Author
-
Skrabal, Christian A., Khosravi, Amir, Choi, Yeong H., Kaminski, Alexander, Westphal, Bernd, Steinhoff, Gustav, and Liebold, Andreas
- Subjects
CARDIOPULMONARY bypass ,ARTIFICIAL blood circulation ,CARDIAC surgery ,CORONARY artery bypass ,MYOCARDIAL revascularization ,HEART blood-vessels - Abstract
Objectives. Retransfusion of pericardial suction blood (PSB) is critically considered under the aspect of the biocompatibility of the cardiopulmonary bypass (CPB). We investigated various indicators of inflammation and blood cell activation associated with CPB and re-transfusion of PSB during cardiac surgery. Design. Thirty-five patients undergoing elective coronary artery bypass grafting were prospectively randomized into two groups. In group A (n = 15, retransfusion group) the pericardial suction blood was continuously retransfused during CPB, in group B (n = 20, no-retransfusion group) the suction blood was separated. Parameters indicating the status of the inflammation and blood cell activation were analyzed before and at the end of CPB, latest after 90 minutes on CPB . Results. Patients’ perioperative data did not differ between groups. The inflammatory markers C-reactive protein, PMN-Elastase and Interleukin-6 increased in both groups after CPB (p<0.04) with significantly lower values in the no-retransfusion group (p<0.02). Leukocytes and platelet activation markers b-Thromboglobulin and soluble P-Selectin also experienced a significant elevation during observation time (p<0.02) without any difference between the groups. Free hemoglobin and LDH tremendously increased during CPB with lower values in the no-retransfusion group. Conclusions. Cardiotomy suction is a major cause of hemolysis and contributes significantly to the systemic inflammatory response. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
47. Evaluation of coated oxygenators in cardiopulmonary bypass systems and their impact on neurocognitive function.
- Author
-
Khosravi, Amir, Skrabal, Christian A., Westphal, Bernd, Kundt, Guenther, Greim, Brigitte, Kunesch, Erwin, Liebold, Andreas, and Steinhoff, Gustav
- Subjects
CORONARY arteries ,HEART blood-vessels ,MYOCARDIAL revascularization ,CORONARY artery bypass ,CORONARY disease ,BLOOD vessels ,HEART failure ,CARDIAC arrest - Abstract
Introduction: Coronary artery bypass graft surgery (CABG) using cardiopulmonary bypass (CPB) is assumed to be associated with a decline of neurocognitive functions. This study was designed to analyse the neurocognitive function of patients with coronary heart disease before and after CABG and to determine possible protective effects of oxygenator surface coating on neurological outcome. Methods: Forty patients scheduled for selective CABG were prospectively randomized into two groups of 20 patients each according to the type of hollow-fibre membrane oxygenator used. Non-coated oxygenators (Group A) were compared to phosphorylcholine (PC)-coated oxygenators (Group B). A battery of six neurological tests was administered preoperatively, 7–10 days and 4–6 months after surgery. Results: One patient of Group A suffered from a perioperative stroke and died on postoperative day 3, presumably because of sudden heart failure. Two patients of Group A (10%) developed a symptomatic transitory delirious psychotic syndrome (STPT) on postoperative days 3 and 5. None of the patients of Group B had perioperative complications. The test analysis revealed a trend of declined neurocognitive function early after CABG, but did not show any difference in neurocognitive outcome between the two groups. Discussion: PC coating of the oxygenators did not show any significant benefit on neurocognitive function after CABG using CPB. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
48. Four Years’ Experience With a Miniaturized Extracorporeal Circulation System and Its Influence on Clinical Outcome.
- Author
-
Wiesenack, Christoph, Liebold, Andreas, Philipp, Alois, Ritzka, Markus, Koppenberg, Joachim, Birnbaum, Dietrich E., and Keyl, Cornelius
- Subjects
CARDIOPULMONARY bypass ,ARTIFICIAL blood circulation ,PATIENTS ,DIAGNOSIS ,CARDIAC surgery ,DISEASES - Abstract
It has been suggested that the morbidity associated with cardiopulmonary bypass can be attributed in part to the blood–material and blood–air interactions in the extracorporeal circulation (ECC). A recently introduced minimized ECC-system (MECC System) should be able to reduce these negative effects associated with ECC. A retrospective analysis was performed comprising 485 patients who were operated on for elective coronary artery bypass grafting (CABG) using the MECC System with intermittent antegrade warm blood cardioplegia (group 1) from January 2000 to February 2004. A control group consisted of 485 patients (group 2) undergoing elective CABG in the same period using a conventional ECC and cold crystalloid cardioplegia. There were no significant differences between the two groups in terms of the duration of intubation following surgery, the length of intensive care unit-stay and the total hospital stay. Although the 30-day mortality was similar between the two groups, the incidence of postoperative complications and the perioperative use of blood products were significantly higher in the control group compared to the MECC group. The MECC System may serve as an alternative and less invasive approach to conventional ECC. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
49. Performance of Temporary Epicardial Stainless Steel Wire Electrodes Used to Treat Atrial Fibrillation: A Study in Patients Following Open Heart Surgery.
- Author
-
Liebold, Andreas, Rödig, Gabriele, and Birnbaum, Dietrich E.
- Subjects
ARRHYTHMIA ,CARDIAC surgery ,DEFIBRILLATORS ,ELECTRONICS in cardiology ,ELECTRIC stimulation - Abstract
AF is the most common arrhythmia following open heart surgery. Transthoracic cardioversion is used when pharmacological treatment fails to restore SH, or is ineffective in controlling ventricular response rate. We report on the performance of temporary atrial defibrillation wire electrodes implanted on the epicardium of patients undergoing open heart surgery. Epicardial stainless steel wire electrodes for both pacing/sensing and atrial defibrillation were placed at the left and right atrium during open heart surgery in 100 consecutive patients (age 65 ± 9 years; male/female 77/23). Electrophysiological studies performed postoperatively revealed a test shock (0.3 J) impedance of 96 ± 12 Ω (monophasic) and 97 ± 13 Ω (biphasic). AF was induced by burst stimulation in 84 patients. All patients were successfully converted to SR. The mean energy of successful shocks was 3.1 ± 1.9 J. Atrial pacing and sensing were accomplished in all patients. Pacing threshold was 1.9 ± 1.7 V (0.5 ms) in the left atrium and 2.1 ± 2 V in the right atrium. P wave sensing was 2.5 ± 1.6 mV in the left atrium and 2.3 ± 1.4 mV in the right atrium. No complications were observed with shock application, nor with lead extraction. Atrial defibrillation using temporary epicardial wire electrodes can be performed successfully and safely in patients following cardiac operations. The shock energy required to restore SR is low. Electrical cardioversion in the absence of anesthesia should be feasible. [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
50. Evaluation of Autosensing as an Automatic Means of Maintaining a 2:1 Sensing Safety Margin in an Implanted Pacemaker.
- Author
-
Castro, Antonio, Liebold, Andreas, Vincente, José, Dungan, Tim, and Allen Jr., John C.
- Subjects
CARDIAC pacemakers ,IMPLANTED cardiovascular instruments ,ARTIFICIAL implants ,ELECTRONICS in cardiology ,PULSE generators ,SIGNAL generators - Abstract
As intracardiac signal amplitudes fluctuate due to patient activity, drug intake, and other factors, it is imperative that an adequate sensing safety margin in an implanted pacemaker be used to compensate. We studied an investigational autosensing feature that automatically adjusts the device's sensitivity. Data were collected from 55 patients, with Intermedics model 292-03 or 294-03 .pacemakers, upon inclusion of the study (Visit 1); 1 month postinclusion (Visit 2); I month, 1 day postinclusion (Visit 3); then 1 month, 2 days postinclusion (Visit 4). Atrial (N = 45) and/or ventricular (N = 54) thresholds were assessed at each visit; during Visit 2, myopotential tests were performed at two sensitivity settings. Autosensing was activated following Visit 1, then programmed on randomly at Visit 2 or Visit 3. From Visit 2- Visit 4, patients were monitored during daily activities (D), exercise (E), and sleep (S) th 24-hour Halter. With Autosensing on, atrial undersensing episodes were D = 33 (p > 0.2), and S = 28 (p < 0.05); ventricular undersensing episodes were D = 6 (p > 0.5). Ventricular oversensing episodes were S = 2; atrial oversensing episodes were S = 34 (p > 0.5), D = 2, and E = 3. Comparing Autosensing adjusted sensitivity with the recommended 2:1 safety margin, 4 patients (p = 0.15) experienced atrial myopotential oversensing, and 2 patients (p = 0.15) ventricular. No unanticipated clinical events occurred. Compared with the recommended 2:1 sensing safety margin, the Autosensing feature performed equal to manual programming in preventing episodes of under/oversensing, and was better for atrial undersensing during sleep. Autosensing obviates the need for periodic reprogramming of a fixed sensitivity value. [ABSTRACT FROM AUTHOR]
- Published
- 1996
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.